ArticleInternal medicine (Tokyo, Japan)2017

Recurrent Subcutaneous Sweet's Disease in a Myelofibrosis Patient Treated with Ruxolitinib before Allogeneic Stem Cell Transplantation.

Teppei Sakoda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.